1-20 of 44
Karen Quillen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Free
Amir Fathi, Alexander Perl, Geoffrey Fell, Brian Jonas, Brittany Ragon, Alice Mims, Uma Borate, Gabriel Mannis, Karen Quillen, Max Stahl, Paul Koller, Andrew Artz, Monzr M. Al Malki, Guido Marcucci, Mary Linton Peters, Timothy Graubert, Peter Westervelt, Philip Amrein, Hanno Hock, Andrew Brunner, Gabriela Hobbs, Rupa Narayan, Michelle Lee, Brandon Aubrey, Alyssa Watson, Richard Hao, Shilton Dhaver, Michael Grunwald, Yi-Bin Chen, Andrew Matthews, Christopher Hourigan, Brent Wood, Donna Neuberg, Areej El-Jawahri, Ibrahim Aldoss
Journal: Blood
Blood (2025) 146 (Supplement 1): 6.
https://doi.org/10.1182/blood-2025-6
Published: 2025
Journal Articles

Dual Bclxl and BCL2 Inhibition with Navitoclax (NAV), Venetoclax (VEN), and Decitabine (DEC) for Advanced Myeloid Neoplasms (MN): Safety and Biological Activity in a Phase 1 Study

Free
Evan C. Chen, Yiwen Liu, Hayden L. Bell, Ilene A. Galinsky, Marlise R. Luskin, Eric S. Winer, Maximilian Stahl, Rahul Vedula, Virginia O. Volpe, Daniel J. DeAngelo, Karen Quillen, Jeremy Ryan, Emma-Jayne Minihane, Matthew Hersch, Rebecca Leonard, Donna S. Neuberg, Richard M. Stone, Anthony G. Letai, Andrew A. Lane, Jacqueline S. Garcia
Journal: Blood
Blood (2024) 144 (Supplement 1): 4580.
https://doi.org/10.1182/blood-2024-198284
Published: 2024
Journal Articles

Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis

Free
Vanessa Fiorini Furtado, MD, Dina Brauneis, ANP, Shayna Sarosiek, MD, Karen Quillen, MDMPH, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-138500
Published: 2020
Journal Articles

Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Free
Camille V Edwards, MD, Dina Brauneis, ANP, Karen Quillen, MDMPH, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-141560
Published: 2020
Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Free
Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4578.
https://doi.org/10.1182/blood-2019-129095
Published: 2019
Journal Articles

Safety of Autologous Stem Cell Transplantation in Patients with Known HTLV-1 Infection: A Case Series of 4 Patients

Free
Vishal K Gupta, MD, Paul White, MD, Vaishali Sanchorawala, MD, Karen Quillen, MD MPH, Shayna Sarosiek, MD, Dina Brauneis, NP, John Mark Sloan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5738.
https://doi.org/10.1182/blood-2018-99-110230
Published: 2018
Journal Articles

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis

Free
Vishal K Gupta, MD, Dina Brauneis, NP, Anthony C Shelton, RN, Karen Quillen, MD MPH, John Mark Sloan, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4616.
https://doi.org/10.1182/blood-2018-99-111551
Published: 2018
Journal Articles

Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation

Free
Clinical Trials & Observations
Shayna Sarosiek, Karen Quillen, J. Mark Sloan, Dina Brauneis, Vaishali Sanchorawala
Journal: Blood
Blood (2018) 132 (7): 755–757.
https://doi.org/10.1182/blood-2018-03-838672
Published: 2018
Journal Articles

Recognizing the Existence of Heparin Induced Thrombocytopenia and Thrombosis in the Setting of High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Case Series

Free
Shayna Sarosiek, MD, Karen Quillen, MDMPH, John Mark Sloan, MD, Dina Brauneis, NP, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3643.
https://doi.org/10.1182/blood.V130.Suppl_1.3643.3643
Published: 2017
Journal Articles

Brachial Plexopathy Following High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation for AL Amyloidosis

Free
Vina Nguyen, MD, Dina Brauneis, NP, John Mark Sloan, MD, Shayna Sarosiek, MD, Karen Quillen, MD, Anthony C Shelton, RN, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5509.
https://doi.org/10.1182/blood.V130.Suppl_1.5509.5509
Published: 2017
Journal Articles

Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation

Free
Clinical Trials & Observations
Sabrina Browning, Karen Quillen, J. Mark Sloan, Gheorghe Doros, Shayna Sarosiek, Vaishali Sanchorawala
Journal: Blood
Blood (2017) 130 (11): 1383–1386.
https://doi.org/10.1182/blood-2017-06-788729
Published: 2017
Journal Articles

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Free
Shin Yin Lee, Robert Meehan, John Mark Sloan, Karen Quillen, Dina Brauneis, Anthony C Shelton, Vaishali Sanchorawala
Journal: Blood
Blood (2015) 126 (23): 5499.
https://doi.org/10.1182/blood.V126.23.5499.5499
Published: 2015
Journal Articles

A Retrospective Review of Engraftment Data for Tbo-Filgrastim Vs. Filgrastim in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation

Free
Taylor Teschner, Stephen Lo, Dina Brauneis, Anthony C Shelton, Bhavesh Shah, John Mark Sloan, Cindy Varga, Karen Quillen, Vaishali Sanchorawala
Journal: Blood
Blood (2015) 126 (23): 5484.
https://doi.org/10.1182/blood.V126.23.5484.5484
Published: 2015
Journal Articles

The Incidence of Atrial Fibrillation Among Patients with AL Amyloidosis Undergoing High Dose Melphalan and Stem Cell Transplantation (HDM/SCT): Experience at a Single Institution

Free
Dina Brauneis, Monica Arun, Frederick L Ruberg, Anthony C Shelton, John Mark Sloan, Karen Quillen, Vaishali Sanchorawala, Cindy Varga
Journal: Blood
Blood (2015) 126 (23): 5490.
https://doi.org/10.1182/blood.V126.23.5490.5490
Published: 2015
Journal Articles

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience

Free
Clinical Trials & Observations
Vaishali Sanchorawala, Fangui Sun, Karen Quillen, J. Mark Sloan, John L. Berk, David C. Seldin
Journal: Blood
Blood (2015) 126 (20): 2345–2347.
https://doi.org/10.1182/blood-2015-08-662726
Published: 2015
Journal Articles

Genes Associated with Alloimmunization to Blood Group Antigens in Sickle Cell Disease

Free
Jacqueline N. Milton, PhD, Allison E. Ashley-Koch, PhD, Melanie E. Garrett, MS, Karen L. Soldano, B.S., Eugene P. Orringer, MD, Paola Sebastiani, PhD, Daniel A. Dworkis, MD PhD, Karen Quillen, MD MPH, Martin H. Steinberg, MD, Marilyn J. Telen, MD
Journal: Blood
Blood (2014) 124 (21): 762.
https://doi.org/10.1182/blood.V124.21.762.762
Published: 2014
Journal Articles

Effect of Severe Hypoalbuminemia on Myelosuppression and Other Toxicities of High Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis Patients

Free
Robert Meehan, MD, David Seldin, MD, John Mark Sloan, MD, Karen Quillen, MD MPH, Dina Brauneis, ANP, Anthony C Shelton, RN, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2014) 124 (21): 5906.
https://doi.org/10.1182/blood.V124.21.5906.5906
Published: 2014
Journal Articles

Long-Term Outcome Of Patients With AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience At a Single Center

Free
Vaishali Sanchorawala, MD, Gheorghe Doros, Karen Quillen, MD, MPH, John Mark Sloan, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Kathleen T Finn, ANP, David C Seldin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3328.
https://doi.org/10.1182/blood.V122.21.3328.3328
Published: 2013
Journal Articles

Proteasome Inhibitor Based Protocol For Antibody Mediated Rejection In Kidney Transplantation

Free
Vaishali Sanchorawala, MD, Karen Quillen, MD, MPH, Amitabh Gautam, MD, Jean M Francis, MD
Journal: Blood
Blood (2013) 122 (21): 4728.
https://doi.org/10.1182/blood.V122.21.4728.4728
Published: 2013
Journal Articles

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

Free
Stephanie B. Tsai, David C. Seldin, Karen Quillen, John L. Berk, Frederick L. Ruberg, Hans Meier-Ewert, J. Mark Sloan, Gheorghe Doros, Kathleen T. Finn, Martha Skinner, Vaishali Sanchorawala
Journal: Blood
Blood (2012) 120 (22): 4445–4446.
https://doi.org/10.1182/blood-2012-09-457341
Published: 2012